Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
IEEE Rev Biomed Eng ; 17: 180-196, 2024.
Article in English | MEDLINE | ID: mdl-37186539

ABSTRACT

Heart rate variability (HRV) is an important metric with a variety of applications in clinical situations such as cardiovascular diseases, diabetes mellitus, and mental health. HRV data can be potentially obtained from electrocardiography and photoplethysmography signals, then computational techniques such as signal filtering and data segmentation are used to process the sampled data for calculating HRV measures. However, uncertainties arising from data acquisition, computational models, and physiological factors can lead to degraded signal quality and affect HRV analysis. Therefore, it is crucial to address these uncertainties and develop advanced models for HRV analysis. Although several reviews of HRV analysis exist, they primarily focus on clinical applications, trends in HRV methods, or specific aspects of uncertainties such as measurement noise. This paper provides a comprehensive review of uncertainties in HRV analysis, quantifies their impacts, and outlines potential solutions. To the best of our knowledge, this is the first study that presents a holistic review of uncertainties in HRV methods and quantifies their impacts on HRV measures from an engineer's perspective. This review is essential for developing robust and reliable models, and could serve as a valuable future reference in the field, particularly for dealing with uncertainties in HRV analysis.


Subject(s)
Cardiovascular Diseases , Electrocardiography , Humans , Heart Rate/physiology , Electrocardiography/methods , Photoplethysmography/methods
2.
J Mater Sci Mater Med ; 32(9): 116, 2021 Aug 30.
Article in English | MEDLINE | ID: mdl-34460000

ABSTRACT

L-glutamate is an important component of protein. It can prevent gastrointestinal damage caused by NSAIDs. We constructed two-phase enteric-coated granules of aspirin and L-glutamate compound by extrusion spheronization method and fluidized bed coating. The subliminal effective dose of L-glutamate is 100 mg/kg tested by model of gastric ulcer of rats induced by aspirin and drug administration. HPLC-UV and UV-Vis methods were adopted to determine content and cumulative release of aspirin and L-glutamate as quality analysis method indexes. The prescription and process optimization were carried out with yield, sphericity and dissolution. The two-phase compound granules have good sphericity of 0.93 ± 0.05 (aspirin pellets) and 0.94 ± 0.02 (L-glutamate pellets), content of salicylic acid (0.24 ± 0.03)%, dissolution of aspirin (2.36 ± 0.11)%. Quality evaluation and preliminary stability meet the commercial requirements. The stored environment of compound preparation should be sealed in a cool and dark place.


Subject(s)
Aspirin , Drug Compounding , Glutamic Acid , Animals , Aspirin/administration & dosage , Aspirin/chemical synthesis , Aspirin/pharmacology , Chemistry, Pharmaceutical/methods , Chemistry, Pharmaceutical/standards , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Compounding/methods , Drug Compounding/standards , Drug Evaluation, Preclinical/methods , Drug Evaluation, Preclinical/standards , Gastric Mucosa/drug effects , Gastrointestinal Tract/drug effects , Glutamic Acid/administration & dosage , Glutamic Acid/chemical synthesis , Glutamic Acid/pharmacology , Quality Control , Rats , Rats, Sprague-Dawley , Stomach Ulcer/drug therapy , Stomach Ulcer/pathology , Tablets, Enteric-Coated
3.
Gastric Cancer ; 22(3): 587-597, 2019 05.
Article in English | MEDLINE | ID: mdl-30426294

ABSTRACT

BACKGROUND: To compare the efficacy of oxaliplatin-based and oxaliplatin-free adjuvant chemotherapies in patients with different Lauren type gastric cancers after D2 gastrectomy. METHODS: From our established gastric cancer database, patients with pathological stage II and III gastric cancer who received adjuvant chemotherapy after D2 gastrectomy at Zhongshan Hospital of Fudan University were analyzed. Patients who received different adjuvant chemotherapy regimens were divided into two subgroups: oxaliplatin-based and oxaliplatin-free subgroup. Clinical outcomes were analyzed according to pathological stage and different Lauren types. RESULTS: From Jan 2010 to June 2017, a total of 580 patients met all the eligibility criteria and were enrolled. The median DFS for all the patients was 24.37 months and the median OS was 56.70 months. In patients with intestinal type gastric cancer, the median DFS of the oxaliplatin-based subgroup was significantly longer than that of oxaliplatin-free subgroup (48.73 vs. 18.33 months, P < 0.001). The median OS was not reached in the oxaliplatin-based subgroup and 54.33 months in the oxaliplatin-free subgroup (P = 0.006). In patients with diffuse type gastric cancer, neither DFS nor OS differed significantly between two subgroups. In multivariate analysis, oxaliplatin-based adjuvant chemotherapy was independent positive predictor of DFS (HR 0.40; 95% CI 0.28-0.59; P < 0.001) and OS (HR 0.35; 95% CI 0.20-0.62; P < 0.001) in patients with intestinal type gastric cancer. CONCLUSIONS: The results of our study suggested that oxaliplatin-based adjuvant chemotherapy was more effective in patients with intestinal type gastric cancer after D2 gastrectomy but showed no more survival benefit in patients with diffuse type.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gastrectomy/methods , Stomach Neoplasms/drug therapy , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Capecitabine/administration & dosage , Chemotherapy, Adjuvant , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Humans , Lymphatic Metastasis , Male , Middle Aged , Oxaliplatin/administration & dosage , Postoperative Care , Prognosis , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Survival Rate
4.
BMC Cancer ; 18(1): 702, 2018 Jun 28.
Article in English | MEDLINE | ID: mdl-29954358

ABSTRACT

BACKGROUND: The aim of this study was to compare the efficacies of the XELOX and DOS regimens as preoperative chemotherapy in patients with locally advanced gastric cancer. METHODS: All cases of locally advanced gastric cancer treated with the XELOX or DOS regimen were reviewed retrospectively. Propensity score matching (PSM) was carried out to reduce selection bias based on age, gender, location, Lauren type, carcinoembryonic antigen level, clinical tumor stage, and clinical node stage. RESULTS: From January 2010 to December 2016, 248 patients were matched; 159 of them received the XELOX regimen and 89 the DOS regimen. The response rates in the XELOX and DOS groups were 34.5 and 38.1%, respectively (P = 0.823). After four cycles of chemotherapy, 111 patients (69.8%) in the XELOX group and 65 patients (73.0%) in the DOS group underwent radical surgery (P = 0.485). The median progression-free survival (33.0 months vs. 18.7 months, P = 0.0356) and the median overall survival (43.8 months vs. 29.1 months, P = 0.0003) were longer for patients who received the DOS regimen than for those who received the XELOX regimen. The occurrence of grade 3 to 4 toxicity was similar in the two groups. CONCLUSIONS: For locally advanced gastric cancer patients, the DOS regimen showed more benefit than the XELOX regimen as preoperative chemotherapy, without any added toxicity effects.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Deoxycytidine/analogs & derivatives , Fluorouracil/analogs & derivatives , Propensity Score , Stomach Neoplasms/drug therapy , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Capecitabine , Chemotherapy, Adjuvant , Deoxycytidine/therapeutic use , Docetaxel/administration & dosage , Drug Combinations , Female , Fluorouracil/therapeutic use , Humans , Male , Middle Aged , Oxaliplatin/administration & dosage , Oxaloacetates , Oxonic Acid/administration & dosage , Retrospective Studies , Stomach Neoplasms/mortality , Tegafur/administration & dosage
5.
J Ethnopharmacol ; 190: 288-300, 2016 Aug 22.
Article in English | MEDLINE | ID: mdl-27286916

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Compound turmeric has been widely used as a remedy for infectious diseases in China. It is a classic multi-herb prescription in traditional Chinese medicine, commonly used in the treatment of enteritis, pneumonia, and abdominal pain for hundreds of years. However, throughout this history, the powder of multi-herbs was directly swallowed, which is currently difficult to administer to patients. The extract of Chinese herbal medicine is made by semi-bionic extraction technology, which is great progress in the modernization of powders of traditional Chinese medicine. The aim of this work is to investigate the protective effects of semi-bionic extraction of compound turmeric (SET) on acute enteritis (AE) induced by dextran sulfate sodium (DSS) in rats. MATERIALS AND METHODS: SET was extracted in artificial gastric juice or artificial intestinal juice and mixed. After vacuum drying, the SET powder was dissolved in distilled water. Adult male Sprague-Dawley rats were randomly divided into six groups. Rats were given salazosulfapyridine (SASP, 175.0mg/kg) or SET (0.42 or 0.21g/kg) before intragastric administration of 5% DSS solutions (0.75g/kg). The treatments lasted 7 days. The food intake in 24h, disease activity index (DAI), and wet/dry (W/D) weight ratios and histological changes in colon tissue were measured. The tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1ß, IL-8, and IL-10 in serum were determined at 1, 4, or 7 d after DSS challenge. Myeloperoxidase (MPO), malonaldehyde (MDA), diamine oxidase (DAO), and glutathione peroxidase (GSH-Px) activities in colon tissue were determined at 7 d. In addition, the nuclear factor-kappa (NF-κ B) and intercellular cell adhesion molecule-1 (ICAM-1) activations in colon tissue were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. RESULTS: In rats with AE, SET significantly reduced DAI at 7 d after DSS treatment, increased the body weight of rats and the food intake in 24h at 3 or 6 d after DSS challenge, and reduced the colon W/D ratio. SET also reduced the TNF-α, IL-6, IL-1ß, and IL-8 in serum and increased IL-10 in serum at 4 and 7 d. In addition, SET decreased MPO, MDA, DAO, and GSH-Px activities in colon and attenuated histological changes in the colon at 7 d after DSS treatment. Further studies demonstrated that SET significantly inhibited NF-κB and ICAM-1 activations in colon tissue. CONCLUSIONS: The current study demonstrated that SET has potent protective effects on DSS-induced AE in rats through its anti-inflammatory and anti-oxidant activities.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Chemical Fractionation/methods , Colitis/prevention & control , Colon/drug effects , Curcuma/chemistry , Dextran Sulfate , Gastrointestinal Agents/pharmacology , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Antioxidants/chemistry , Antioxidants/isolation & purification , Colitis/blood , Colitis/chemically induced , Colitis/pathology , Colon/metabolism , Colon/pathology , Cytokines/blood , Disease Models, Animal , Gastric Juice/chemistry , Gastrointestinal Agents/chemistry , Gastrointestinal Agents/isolation & purification , Gene Expression Regulation , Inflammation Mediators/blood , Intestinal Secretions/chemistry , Male , Oxidative Stress/drug effects , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plants, Medicinal , Rats, Sprague-Dawley , Time Factors
6.
J Tradit Chin Med ; 35(3): 355-60, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26237843

ABSTRACT

Powder formulae are an indispensable part of prescription in Traditional Chinese Medicine. Powder formulae are. characterized by good therapeutic efficacy and low dose used for their preparation. Analysis of the therapeutic application and material basis of pharmacological active substance in power formulae can enable the development of new powder formulae. This in turn can contribute to reduction of wastage of drug material, relief of shortage of herbal medicinal resources and sustainable development of Traditional Chinese Medicine.


Subject(s)
Chemistry, Pharmaceutical , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Animals , Drug Therapy , Humans , Medicine, Chinese Traditional
7.
J Environ Sci (China) ; 26(8): 1751-62, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-25108732

ABSTRACT

Excess phosphorus from non-point pollution sources is one of the key factors causing eutrophication in many lakes in China, so finding a cost-effective method to remove phosphorus from non-point pollution sources is very important for the health of the aqueous environment. Graphene was selected to support nanoscale zero-valent iron (nZVI) for phosphorus removal from synthetic rainwater runoff in this article. Compared with nZVI supported on other porous materials, graphene-supported nZVI (G-nZVI) could remove phosphorus more efficiently. The amount of nZVI in G-nZVI was an important factor in the removal of phosphorus by G-nZVI, and G-nZVI with 20 wt.% nZVI (20% G-nZVI) could remove phosphorus most efficiently. The nZVI was very stable and could disperse very well on graphene, as characterized by transmission electron microscopy (TEM) and scanning electron microscopy (SEM). X-ray photoelectron spectroscopy (XPS), Fourier Transform infrared spectroscopy (FT-IR) and Raman spectroscopy were used to elucidate the reaction process, and the results indicated that Fe-O-P was formed after phosphorus was adsorbed by G-nZVI. The results obtained from X-ray diffraction (XRD) indicated that the reaction product between nZVI supported on graphene and phosphorus was Fe3(PO4)2·8H2O (Vivianite). It was confirmed that the specific reaction mechanism for the removal of phosphorus with nZVI or G-nZVI was mainly due to chemical reaction between nZVI and phosphorus.


Subject(s)
Graphite/chemistry , Iron/chemistry , Nanostructures/chemistry , Phosphorus/chemistry , Water/chemistry , Adsorption , Water Pollutants, Chemical
8.
Zhong Yao Cai ; 36(11): 1853-7, 2013 Nov.
Article in Chinese | MEDLINE | ID: mdl-24956828

ABSTRACT

OBJECTIVE: To optimize the extracting technology from Angelica sinensis by central composite design-response surface methodology. METHODS: On the basis of the single factor,independent variables were ethanol concentrations, solvent ratio and ultrasonic time, while dependent variable was the OD value of extraction rates of ferulic acid and liqustilide. A two-order polynomial equation was fitted to estimate the relationship between independent and dependent variables. Response surface method was used to optimize the extracting process. RESULTS: The optimum extraction conditions for Angelica sinesis were obtained as follows: the extracting solvent was methanol concentrations of 70%, 30 fold solvent, extracting for once and for 40 minutes. The deviation between observed and predicted values was 1.23%. CONCLUSION: The result indicates that the central composite design and response surface methodology is simple, convenient and reliable for optimizing the extraction process of Angelica sinesis with higher precision.


Subject(s)
4-Butyrolactone/analogs & derivatives , Angelica sinensis/chemistry , Coumaric Acids/isolation & purification , Technology, Pharmaceutical/methods , 4-Butyrolactone/chemistry , 4-Butyrolactone/isolation & purification , Chromatography, High Pressure Liquid , Coumaric Acids/chemistry , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Methanol/chemistry , Models, Statistical , Plant Roots/chemistry , Reproducibility of Results , Solvents/chemistry
9.
Zhong Yao Cai ; 34(8): 1196-9, 2011 Aug.
Article in Chinese | MEDLINE | ID: mdl-22233032

ABSTRACT

OBJECTIVE: To choose the optimum initial processing methods of Rheum palmatum. METHODS: Fresh crude Rheum palmatum was sliced and dealt with the different drying methods such as sun drying, shady drying, microwave heating and various temperatures drying. The content of the Anthraquinones derivatives, slicing colors and dried rates were used as evaluation indexes. The sliced Rheum palmatum was compared with the traditional processing. RESULTS: Sliced fresh crude Rheum palmatum had the low content of the Anthraquinones derivatives and dry rates, slicing colours had obviously changes. For various drying methods, smoking drying was superior to sun drying, shady drying, microwave heating and various temperatures drying methods. CONCLUSION: Fresh crude Rheum palmatum is not suitable for slicing processing. The best drying method is smoking drying.


Subject(s)
Anthraquinones/analysis , Desiccation/methods , Plants, Medicinal/chemistry , Rheum/chemistry , Chromatography, High Pressure Liquid , Microwaves , Plant Roots/chemistry , Plants, Medicinal/growth & development , Quality Control , Reproducibility of Results , Rheum/growth & development , Rhizome/chemistry , Technology, Pharmaceutical/methods
10.
Fitoterapia ; 78(1): 12-5, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17084991

ABSTRACT

The effects of Dioscorea opposita (huai shan yao, HSY) on dexamethasone-induced insulin resistance were investigated in vitro and in vivo. D. opposita extract reduced significantly the blood insulin and glucose levels in dexamethasone-induced diabetic rats. In vitro, HSY significantly enhanced insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Moreover, HSY increase the mRNA expression of GLUT4 glucose transporter in 3T3-L1 adipocytes. These data suggest that D. opposita has insulin sensitivity that is associated with the regulation of GLUT4 expression.


Subject(s)
Dioscorea , Hypoglycemic Agents/pharmacology , Insulin/metabolism , Phytotherapy , Plant Extracts/pharmacology , Adipocytes/drug effects , Adipocytes/metabolism , Administration, Oral , Animals , Blood Glucose/metabolism , Dexamethasone , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Female , Glucose Transporter Type 4/genetics , Glucose Transporter Type 4/metabolism , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Insulin/blood , Male , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL